IXICO (LON:IXI) Releases Earnings Results

IXICO (LON:IXI) posted its earnings results on Tuesday. The company reported GBX (1.21) earnings per share (EPS) for the quarter, Digital Look Earnings reports. The company had revenue of GBX 395 million for the quarter. IXICO had a negative return on equity of 13.74% and a negative net margin of 25.27%.

IXICO Stock Performance

LON IXI opened at GBX 8 on Tuesday. The firm has a 50-day moving average of GBX 7.34 and a 200-day moving average of GBX 9.48. The company has a debt-to-equity ratio of 1.53, a quick ratio of 4.90 and a current ratio of 3.03. The stock has a market cap of £17.44 million, a PE ratio of -4.32, a P/E/G ratio of -0.38 and a beta of 0.07. IXICO has a 52-week low of GBX 6.26 and a 52-week high of GBX 15.

IXICO Company Profile

IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.

By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.